Cytochrome P450 ubiquitination: Branding for the proteolytic slaughter?

被引:42
作者
Correia, MA [1 ]
Sadeghi, S [1 ]
Mundo-Paredes, E [1 ]
机构
[1] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA
关键词
ERAD; 26S proteasome; Ubc7p; HRD/DER; CYP3A4; CYP2C11;
D O I
10.1146/annurev.pharmtox.45.120403.100127
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The hepatic cytochromes P450 (P450s) are monotopic endoplasmic reticulum (ER)-anchored hemoproteins engaged in the enzymatic oxidation of a wide variety of endo- and xenobiotics. In the course of these reactions, the enzymes generate reactive O-2 species and/or reactive metabolic products that can attack the P450 heme and/or protein moiety and structurally and functionally damage the enzyme. The in vivo conformational unraveling of such a structurally damaged P450 signals its rapid removal via the cellular sanitation system responsible for the proteolytic disposal of structurally aberrant, abnormal, and/or otherwise malformed proteins. A key player in this process is the ubiquitin (Ub)-dependent 26S proteasome system. Accordingly, the structurally deformed P450 protein is first branded for recognition and proteolytic removal by the 26S proteasome with an enzymatically incorporated polyUb tag. P450s of the 3A subfamily such as the major human liver enzyme CYP3A4 are notorious targets for this process, and they represent excellent prototypes for the understanding of integral ER protein ubiquitination. Not all the participants in hepatic CYP3A ubiquitination and subsequent proteolytic degradation have been identified. The following discussion thus addresses the various known and plausible events and/or cellular participants involved in this multienzymatic P450 ubiquitination cascade, on the basis of our current knowledge of other eukaryotic models. In addition, because the detection of ubiquitinated P450s is technically challenging, the critical importance of appropriate methodology is also discussed.
引用
收藏
页码:439 / 464
页数:30
相关论文
共 131 条
[1]   JAMM: A metalloprotease-like zinc site in the proteasome and signalosome [J].
Ambroggio, XI ;
Rees, DC ;
Deshaies, RJ .
PLOS BIOLOGY, 2004, 2 (01) :113-119
[2]  
Banerjee A, 2000, DRUG METAB DISPOS, V28, P118
[3]   RABBIT P450 2E1-EXPRESSED IN CHO-K1 CELLS HAS A SHORT HALF-LIFE [J].
BARMADA, S ;
KIENLE, E ;
KOOP, DR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 206 (02) :601-607
[4]   The proteasome:: Paradigm of a self-compartmentalizing protease [J].
Baumeister, W ;
Walz, J ;
Zühl, F ;
Seemuller, E .
CELL, 1998, 92 (03) :367-380
[5]   Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation [J].
Bays, NW ;
Gardner, RG ;
Seelig, LP ;
Joazeiro, CA ;
Hampton, RY .
NATURE CELL BIOLOGY, 2001, 3 (01) :24-29
[6]   HRD4/NPL4 is required for the proteasomal processing of ubiquitinated ER proteins [J].
Bays, NW ;
Wilhovsky, SK ;
Goradia, A ;
Hodgkiss-Harlow, K ;
Hampton, RY .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (12) :4114-4128
[7]   HUMAN ANTI-ENDOPLASMIC RETICULUM AUTOANTIBODIES APPEARING IN A DRUG-INDUCED HEPATITIS ARE DIRECTED AGAINST A HUMAN-LIVER CYTOCHROME-P-450 THAT HYDROXYLATES THE DRUG [J].
BEAUNE, P ;
DANSETTE, PM ;
MANSUY, D ;
KIFFEL, L ;
FINCK, M ;
AMAR, C ;
LEROUX, JP ;
HOMBERG, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (02) :551-555
[8]   Role of Cue1p in ubiquitination and degradation at the ER surface [J].
Biederer, T ;
Volkwein, C ;
Sommer, T .
SCIENCE, 1997, 278 (5344) :1806-1809
[9]   De3p/Hrd1p is required for endoplasmic reticulum-associated degradation of misfolded lumenal and integral membrane proteins [J].
Bordallo, J ;
Plemper, RK ;
Finger, A ;
Wolf, DH .
MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (01) :209-222
[10]  
BOURDI M, 1992, MOL PHARMACOL, V42, P280